Market Trends of Benzodiazepine Drugs Industry
This section covers the major market trends shaping the Benzodiazepine Drugs Market according to our research experts:
Anxiety Disorders Segment is Expected to Hold a Largest Market Share in the Benzodiazepine Drugs
Anxiety segment is anticipated to account for major share of the market during the forecast period.According to World Health Organization (WHO) estimated number of people living with anxiety disorders globally is 264 million in the year 2015 reflects a 14.9% increase since 2005, as a result of population growth and ageing and which is estimated to be 3.6%. Anxiety disorders are more common among females than males (4.6% in females compared to 2.6% in males at the global level).
In 2017, anxiety segment recorded more than 60% revenue share collectively with anti-depressants drugs and the boost in demand for anxiety therapeutics coupled with a rise in a number of companies investing to develop new anxiety drugs which drives the market revenue. Anxiety was a dominant segment of the benzodiazepines drug market globally in the year 2017 and expected to maintain same during the forecast period.
North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period
North America is expected to hold a dominating position in the global benzodiazepine drugs market due to more FDA approvals in that region. Around 40 million adults in the United States are affected every year with anxiety disorders of which only 36.9% receive treatment according to Anxiety and Depression Association of America (ADAA). Increase in the development of mental health-care services and rising awareness towards anxiety disorders are responsible for the increase in the diagnosis of generalized anxiety disorder (GAD). Due to growth in geriatric population is increasing the anxiety diagnosis rates in Mexico, thus directly boosting the demand for physiotherapies such as Cognitive Behavior Therapy (CBT) and generalized anxiety disorder (GAD) medication.